SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-023789
Filing Date
2021-10-18
Accepted
2021-10-18 08:25:27
Documents
15
Period of Report
2021-10-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20211015_8k.htm   iXBRL 8-K 21545
2 EXHIBIT 99.1 ex_291859.htm EX-99.1 22349
7 moleculinlogoresizedclear.jpg GRAPHIC 19339
  Complete submission text file 0001437749-21-023789.txt   239620

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20211018.xsd EX-101.SCH 3594
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20211018_def.xml EX-101.DEF 12188
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20211018_lab.xml EX-101.LAB 16397
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20211018_pre.xml EX-101.PRE 12458
8 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20211015_8k_htm.xml XML 2737
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 211327386
SIC: 2834 Pharmaceutical Preparations